Subsense emerges from stealth with $17m for nanoparticle BCI development
Subsense has emerged from stealth with $17m in seed financing as the company aims to develop a new type of brain-computer interface (BCI). The post Subsense emerges from stealth with $17m for nanoparticle BCI development appeared first on Medical Device Network.
Subsense has emerged from stealth with $17m in seed financing as the company aims to develop a new type of brain-computer interface (BCI).
The post Subsense emerges from stealth with $17m for nanoparticle BCI development appeared first on Medical Device Network.
